Clearside Biomedical
CLSD
$1.34
Share price
6.35%
Change (1 day)
31.37%
Change (1 year)
Categories
Clearside Biomedical (CLSD) - P/B ratio
P/B ratio as of April 2024 : -6.15
According to Clearside Biomedical
's latest financial reports the company has a price-to-book ratio of -6.15.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Clearside Biomedical - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -4.59 | -172.2% |
| 2022-12-31 | 6.36 | 47.09% |
| 2021-12-31 | 4.32 | -71.42% |
| 2020-12-31 | 15.1 | 30.97% |
| 2019-12-31 | 11.5 | 693.41% |
| 2018-12-31 | 1.46 | -82.44% |
| 2017-12-31 | 8.28 | 222.82% |
| 2016-12-31 | 2.57 | |
| 2015-12-31 | N/A | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -139.47% | 🇺🇸 USA |